Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Jun 3;26(6):euae147.
doi: 10.1093/europace/euae147.

Enhancing the study on antithrombotic therapy after stroke in AF patients

Shen Wang  1   2
Affiliations
Editorial

Enhancing the study on antithrombotic therapy after stroke in AF patients

Shen Wang. Europace. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: There is no conflict of interest to disclose.

Similar articles

See all similar articles

References

    1. Ahn HJ, Lee SR, Choi J, Lee KY, Kwon S, Choi EK et al. Association between antithrombotic therapy after stroke in patients with atrial fibrillation and the risk of net clinical outcome: an observational cohort study. Europace 2024;26:euae033. - PMC - PubMed
    1. Breitenstein A, Gay A, Vogtlander K, Fox KAA, Steffel J, Committee XP. The net clinical outcome of dual-pathway inhibition in clinical practice: the “Xarelto plus acetylsalicylic acid: treatment patterns and outcomes in patients with atherosclerosis”. registry. J Clin Med 2024;13:1956. - PMC - PubMed
    1. Fanola CL, Giugliano RP, Ruff CT, Trevisan M, Nordio F, Mercuri MF et al. A novel risk prediction score in atrial fibrillation for a net clinical outcome from the ENGAGE AF-TIMI 48 randomized clinical trial. Eur Heart J 2017;38:888–96. - PubMed
    1. Gencer B, Eisen A, Berger D, Nordio F, Murphy SA, Grip LT et al. Edoxaban versus Warfarin in high-risk patients with atrial fibrillation: a comprehensive analysis of high-risk subgroups. Am Heart J 2022;247:24–32. - PubMed
    1. Yamato H, Abe K, Osumi S, Yanagisawa D, Kodashima S, Asaoka Y et al. Clinical factors associated with safety and efficacy in patients receiving direct oral anticoagulants for non-valvular atrial fibrillation. Sci Rep 2020;10:20144. - PMC - PubMed

Publication types